article thumbnail

10 of the Worst Food Safety Scandals in Recent History

XTalks

While food safety regulations and advances in technology have greatly reduced the incidence of such events, some of the worst food safety incidents continue to occur. The outbreak had a significant impact on the spinach industry, with an estimated loss of $74 million in sales.

article thumbnail

What is a natural health product? Health Canada’s findings upheld by Federal Courts

Pharma in Brief

The Courts’ decisions provide insight into how natural health products are distinguished, under federal law, from cosmetics and from drugs subject to the Food and Drug Regulations. These distinctions are important as they determine the regulatory burden required to market a product in Canada.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Valneva accelerates Lyme disease vaccine R&D project with Pfizer

pharmaphorum

Subject to approval from regulators the vaccine specialist said it plans the trial known as VLA15-221 as a randomised, observer-blind phase 2 study including around 600 healthy people aged 5-65 years of age. OspA is one of the most dominant surface proteins expressed by the bacteria when present in the ticks that spread the disease.

article thumbnail

Pfizer’s seeks silver lining in failed C. diff vaccine trial

pharmaphorum

The company came out with the usual mantra of evaluating the data and conferring with regulators before deciding on the future of the programme, and said it would present the data in full at an future medical congress. PF-06425090 has been held up as one of the top prospects in Pfizer’s pipeline, with blockbuster sales potential.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. billion in pharmaceutical sales from 2021. In contrast, several drugs experienced sale declines, such as Remicade (infliximab), an old immunology medication that continues to decline due to the rise of biosimilars since 2016.

Sales 98